XPF-002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for XPF-002, covering 2013-11-25 to 2014-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia [Phase 1, Phase 2]